Full metadata record
DC FieldValueLanguage
dc.creatorRodríguez-Pérez, M.C. (María C.)-
dc.creatorSánchez-Espirilla, S. (Saida)-
dc.creatorPereira-Vega, A. (Antonio)-
dc.creatorCallejón-Leblic, B. (Belén)-
dc.creatorDíaz-Olivares, I. (Isabel)-
dc.creatorSantana, R. (Rafael)-
dc.creatorGotera-Rivera, C. (Carolina)-
dc.creatorGómez-Ariza, J. L. (José Luis)-
dc.creatorLopez-Campos, J.L. (José Luis)-
dc.creatorBlanco-Orozco, A. I. (Ana Isabel)-
dc.creatorSeijo, L. (Luis)-
dc.creatorPadrón-Fraysse, L. A. (Luis Alejandro)-
dc.creatorHerrera-Chilla, A. (Ángeles)-
dc.creatorPeces-Barba, G. (German)-
dc.creatorGarcía-Barrera, T. (Tamara)-
dc.date.accessioned2024-02-09T17:33:35Z-
dc.date.available2024-02-09T17:33:35Z-
dc.date.issued2023-
dc.identifier.citationRodríguez-Pérez, M.C. (María C.); Sánchez-Espirilla, S. (Saida); Pereira-Vega, A. (Antonio); et al. "Untargeted Metabolomic Study of Lung Cancer Patients after Surgery with Curative Intent". Jounal of Proteome Research. 22, 2023, 3499 - 3507es_ES
dc.identifier.urihttps://hdl.handle.net/10171/69032-
dc.description.abstractLung cancer (LC) is a leading cause of mortality, claiming more than 1.8 million deaths per year worldwide. Surgery is one of the most effective treatments when the disease is in its early stages. The study of metabolic alterations after surgical intervention with curative intent could be used to assess the response to treatment or the detection of cancer recurrence. In this study, we have evaluated the metabolomic profile of serum samples (n = 110) from preoperative (PRE) and postoperative (POST) LC patients collected at two different time points (1 month, A; 3–6 months, B) with respect to healthy people. An untargeted metabolomic platform based on reversed phase (RP) and hydrophilic interaction chromatography (HILIC), using ultra-high performance liquid chromatography (UHPLC) and mass spectrometry (MS), was applied (MassIVE ID MSV000092213). Twenty-two altered metabolites were annotated by comparing all the different studied groups. DG(14,0/22:1), stearamide, proline, and E,e-carotene-3,3′-dione were found altered in PRE, and their levels returned to those of a baseline control group 3–6 months after surgery. Furthermore, 3-galactosyllactose levels remained altered after intervention in some patients. This study provides unique insights into the metabolic profiles of LC patients after surgery at two different time points by combining complementary analytical methods.es_ES
dc.language.isoenges_ES
dc.rightsinfo:eu-repo/semantics/openAccesses_ES
dc.subjectMetabolomicses_ES
dc.subjectMass spectrometryes_ES
dc.subjectHydrophilic interactiones_ES
dc.subjectLung canceres_ES
dc.subjectSerumes_ES
dc.subjectSurgeryes_ES
dc.subjectUltra-high performance liquid chromatographyes_ES
dc.titleUntargeted Metabolomic Study of Lung Cancer Patients after Surgery with Curative Intentes_ES
dc.typeinfo:eu-repo/semantics/articlees_ES
dc.relation.publisherversionhttps://pubs.acs.org/doi/10.1021/acs.jproteome.3c00356es_ES
dc.editorial.note© 2023 The Authors. Published by American Chemical Society. CCBY 4. 0. Licensees_ES
dadun.citation.endingPage3507es_ES
dadun.citation.publicationNameJounal of Proteome Researches_ES
dadun.citation.startingPage3499es_ES
dadun.citation.volume22es_ES

Files in This Item:
Thumbnail
File
Aportación 18.pdf
Description
Size
3.06 MB
Format
Adobe PDF


Statistics and impact
0 citas en
0 citas en

Items in Dadun are protected by copyright, with all rights reserved, unless otherwise indicated.